)
Biotricity (BTCY) investor relations material
Biotricity Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved third consecutive quarter of positive net operating income and EBITDA, reflecting disciplined execution, operational efficiency, and recurring technology fees and device sales growth.
Rapid expansion of digital ecosystem, with app users growing from 4,500 to over 44,000 in two years and a provider network supporting up to 4 million patients annually.
High customer retention rate exceeding 90%, driven by solution quality and customer support.
Demand for remote patient management and chronic cardiac care solutions continues to accelerate, driven by an aging population and healthcare staffing shortages.
Strategic initiatives and technological advancements, including AI-enabled solutions, position the company for sustained growth and profitability in 2026.
Financial highlights
Revenue for Q3 FY2026 increased 10.2% year-over-year to $4 million, and $11.7 million for the nine months ended December 31, 2025, up 16.5% year-over-year.
Gross margin improved to 81.5% for Q3 FY26, and 81.3% for the nine months, up from 76.4% and 75.2% respectively.
Operating expenses decreased 4.2% to $2.8 million for the quarter, and 6.8% to $8.55 million for the nine months, with SG&A down and R&D up.
Net loss attributable to common stockholders narrowed to $1.1 million ($0.042 per share) for the quarter, and $2.08 million for the nine months.
Free cash flow positive for six consecutive quarters, with $1.8 million generated for the nine months.
Outlook and guidance
Expects continued strong adoption of Biotres Pro and further top-line revenue growth in 2026, with ongoing investment in R&D and commercialization of new products.
Anticipates achieving net income profitability within the year, building on current positive trends.
Focus remains on U.S. market expansion, with opportunistic international growth through distribution partnerships and regulatory approvals.
Company expects existing cash and anticipated near-term financings to meet needs for the next twelve months, but additional capital may be required for further expansion.
Next Biotricity earnings date
Next Biotricity earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)